Morgan Stanley’s CoLucid Pharmaceuticals, Inc. CLCD Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q1 | – | Sell |
-13,723
| Closed | -$499K | – | 6714 |
|
|
2016
Q4 | $499K | Buy |
13,723
+986
| +8% | +$35.9K | ﹤0.01% | 4933 |
|
|
2016
Q3 | $486K | Buy |
12,737
+12,237
| +2,447% | +$467K | ﹤0.01% | 4541 |
|
|
2016
Q2 | $4K | Sell |
500
-9,300
| -95% | -$74.4K | ﹤0.01% | 6280 |
|
|
2016
Q1 | $61K | Buy |
9,800
+7,500
| +326% | +$46.7K | ﹤0.01% | 5530 |
|
|
2015
Q4 | $19K | Buy |
2,300
+1,800
| +360% | +$14.9K | ﹤0.01% | 6060 |
|
|
2015
Q3 | $2K | Sell |
500
-5,912
| -92% | -$23.6K | ﹤0.01% | 6505 |
|
|
2015
Q2 | $57K | Buy |
+6,412
| New | +$57K | ﹤0.01% | 5815 |
|